Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760)

Basic

  • Market Cap

    CN¥346.22B

  • EV

    CN¥326.82B

  • Shares Out

    1,209.39M

  • Revenue

    CN¥34.37B

  • Employees

    16,099

Margins

  • Gross

    65.41%

  • EBITDA

    38.11%

  • Operating

    35.67%

  • Pre-Tax

    37.56%

  • Net

    32.99%

  • FCF

    30.8%

Returns (5Yr Avg)

  • ROA

    14.66%

  • ROE

    31.59%

  • ROCE

    30.94%

  • ROIC

    44.79%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    CN¥396.55

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    CN¥28.4

  • Earnings (Dil)

    CN¥9.36

  • FCF

    CN¥8.74

  • Book Value

    CN¥30.42

Growth (CAGR)

  • Rev 3Yr

    19.31%

  • Rev 5Yr

    21.26%

  • Rev 10Yr

    —

  • Dil EPS 3Yr

    21.32%

  • Dil EPS 5Yr

    23.93%

  • Dil EPS 10Yr

    —

  • Rev Fwd 2Yr

    18.94%

  • EBITDA Fwd 2Yr

    16.45%

  • EPS Fwd 2Yr

    20.59%

  • EPS LT Growth Est

    20.63%

Dividends

  • Yield

    —

  • Payout

    93.94%

  • DPS

    CN¥8.8

  • DPS Growth 3Yr

    80.36%

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    17.82%

Select a metric from the list below to chart it

Dec '14
Dec '16
Dec '18
Dec '20
Dec '22
Metric
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Jan '22
Dec '22
LTM

Revenues

13,710.1

16,519.6

20,981.0

25,257.8

30,353.8

34,361.8

Other Revenues, Total

43.2

36.4

44.9

11.7

11.8

11.8

Total Revenues

13,753.4

16,556.0

21,025.8

25,269.6

30,365.6

34,373.6

Total Revenues % Chg.

23.1%

20.4%

27.0%

20.2%

20.2%

17.8%

Cost of Goods Sold, Total

4,626.4

5,799.2

7,459.5

8,967.0

10,955.6

11,890.4

Gross Profit

9,127.0

10,756.8

13,566.4

16,302.6

19,410.0

22,483.2

Selling General & Admin Expenses, Total

3,917.3

4,370.7

4,509.1

5,104.6

6,121.6

6,965.4

Provision for Bad Debts

20.1

8.8

29.7

-6.7

37.1

87.3

R&D Expenses

1,267.2

1,465.6

1,869.3

2,524.2

2,922.6

3,344.2

Other Operating Expenses

-127.3

-81.8

-100.8

-83.1

-80.4

-173.4

Other Operating Expenses, Total

5,077.3

5,763.3

6,307.2

7,539.0

9,001.0

10,223.5

Operating Income

4,049.7

4,993.5

7,259.1

8,763.6

10,409.0

12,259.7

Interest Expense, Total

-42.5

—

—

-8.6

-10.7

-11.9

Interest And Investment Income

90.7

331.3

385.7

408.1

357.9

631.0

Net Interest Expenses

48.2

331.3

385.7

399.5

347.2

619.2

Income (Loss) On Equity Invest.

—

—

-4.5

—

—

-1.0

Currency Exchange Gains (Loss)

189.1

156.3

-253.4

-227.7

172.0

172.0

Other Non Operating Income (Expenses)

-81.4

-79.7

-70.9

-85.9

-67.8

-239.5

EBT, Excl. Unusual Items

4,205.5

5,401.4

7,316.1

8,849.5

10,860.4

12,810.4

Impairment of Goodwill

—

-94.5

—

—

—

—

Gain (Loss) On Sale Of Investments

-0.0

—

—

9.9

-26.4

55.8

Gain (Loss) On Sale Of Assets

-3.0

-1.5

-2.1

4.1

6.2

4.4

Asset Writedown

-1.9

-18.1

-16.9

-7.5

-0.7

-72.5

Legal Settlements

-17.3

2.4

-2.4

-5.7

-3.3

-3.3

Other Unusual Items

55.0

78.5

143.7

166.8

117.5

117.5

EBT, Incl. Unusual Items

4,238.3

5,368.3

7,438.4

9,017.1

10,953.6

12,912.3

Income Tax Expense

512.6

683.4

778.8

1,013.0

1,342.8

1,571.8

Earnings From Continuing Operations

3,725.7

4,684.8

6,659.6

8,004.0

9,610.7

11,340.5

Minority Interest

-6.5

-4.2

-1.9

-2.5

-3.5

-1.3

Net Income

3,719.2

4,680.6

6,657.7

8,001.6

9,607.2

11,339.1

Net Income to Common Incl Extra Items

3,719.2

4,680.6

6,657.7

8,001.6

9,607.2

11,339.1

Net Income to Common Excl. Extra Items

3,719.2

4,680.6

6,657.7

8,001.6

9,607.2

11,339.1

Total Shares Outstanding

1,215.7

1,215.7

1,215.7

1,212.6

1,209.4

1,210.3

Weighted Avg. Shares Outstanding

1,113.5

1,215.7

1,215.7

1,214.8

1,209.9

1,210.5

Weighted Avg. Shares Outstanding Dil

1,113.5

1,215.7

1,215.7

1,214.8

1,210.4

1,211.4

EPS

3.3

3.9

5.5

6.6

7.9

9.4

EPS Diluted

3.3

3.9

5.5

6.6

7.9

9.4

EBITDA

4,381.1

5,387.8

7,731.3

9,380.1

11,152.4

13,098.3